Patent search ap:("ECCOGENE (SHANGHAI) CO. Page LTD.") AND inv:"SUN

1.

发明申请
SSAO INHIBITORS AND USE THEREOF 审中-公开

公开(公告)号：WO2021083209A1

公开(公告)日：2021-05-06

申请号：PCT/CN2020/124381

申请日：2020-10-28

Applicant: ECCOGENE (SHANGHAI) CO., LTD.

Inventor： REN, Zaifang , SUN, Xuefeng , XU, Qing

IPC: C07D309/04 , C07D319/12 , C07D309/10 , C07D309/08 , C07C317/14 , C07D307/10 , C07D309/12 , C07D211/46 , C07D309/06 , C07D205/04 , C07D275/02 , C07D207/06 , C07D401/04 , C07D295/08 , A61K31/10 , A61P3/00 , A61P9/00 , A61P29/00

Abstract: Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.

2.

发明申请
PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-PHENYL-, PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-HETEROARYL-, OR PHENYL- [1, 3] DIOXOLO [4, 5-C] PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO [D] IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME 审中-公开

公开(公告)号：WO2022199661A1

公开(公告)日：2022-09-29

申请号：PCT/CN2022/082788

申请日：2022-03-24

Applicant: ECCOGENE (SHANGHAI) CO., LTD.

Inventor： REN, Zaifang , SUN, Xuefeng , ZHOU, Jingye

IPC: C07D401/04 , C07D405/04 , C07D417/14 , C07D487/04 , A61K31/497 , A61P3/10

Abstract: Provided is compound of Formula (Y) or Formula (A) or pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.

3.

发明申请
TETRAHYDROPYRAZOLO-PYRAZINYL-DIHYDROIMIDAZOLONE OR TETRAHYDROPYRAZOLO-PYRIDINYL-DIHYDROIMIDAZOLONE COMPOUNDS AND METHODS OF USING SAME 审中-公开

公开(公告)号：WO2022017338A1

公开(公告)日：2022-01-27

申请号：PCT/CN2021/107216

申请日：2021-07-20

Applicant: ECCOGENE (SHANGHAI) CO., LTD.

Inventor： REN, Zaifang , SUN, Xuefeng , ZHOU, Jingye , XU, Qing

IPC: A61P1/16 , A61P3/04 , A61P3/06 , A61P9/00 , A61P25/16 , A61P25/28 , C07D471/04 , C07D487/04

Abstract: The application relates to a compound of Formula (I) : or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of GLP-1 receptor, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which GLP-1 receptor plays a role.

Patent Agency Ranking